2[2]Kato H,Sugimura T,Akagi T,et al.Long- term consequences of Kawasaki disease:a 10 to 21 year follow-up study of 594 patients[J].Circulation,1996,94(6):1379-1385.
3[3]Nigro G,Zerbini M,Krzysztofiak A,et al.Active or recent parovirus B19 infection in children with Kawasaki disease[J],Lancet,1994,343(8908):1260-1261.
4[4]Burns JC,Shike H,Cordon JB,et al.Squelae of Kawasaki disease in adolescents and young adults[ J].J Am Coll Cardiol,1996,28( 1 ):253-257.
5[5]Shulman ST,Inocencio JD,Hirsch R.Kawasaki disease [ J].Pediatr Clin North Am,1995,42(5):1205-1222.
6[6]Rowley AH,Shulman ST.Kawasaki syndrome [ J ].Pediatr Clin North Am,1999,46(2):313-329.
7[7]Yanagawa H,Nakemura Y,Yashiro M,et al.Update of the epidemiology of Kawasaki disease in Japan:from the result of the 1993-1994 nation - wide survey[J] .J Epidemiol,1996,6(3):148-157.
8[8]Dajani AS,Taubert KA,Gerber MA,et al.Special report:diagnosis and therapy of kawasak disease in children[J].Circulation,1993,87(5):1776-1780.
9[9]Kato H,Ichinose E,Kawasaki T.Myocardial infarction in Kawasaki disease:clinical analysis in 195 cases[J] .J Pediatr,1986,108(6):923-927.
10[10]Dajani AS,Taubert KA,Takahashi M,et al.Special report:Guidelines for long term management of patients with Kawasaki disease[J].Circulation,1994,89(2):916-922.
7Kawasaki T. Acute febrile mucocutaneous lymph node syndrome: clinical observations of 50 cases. Jpn J Allergy, 1967, 16: 178-222.
8Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease. Pediatric Int, 2005, 47: 232-235.
9Freeman AF, Shulman ST. Recent developments in Kawasaki disease. Curr Opin Infect Dis, 2001, 14: 357-361.
10Yanmkawa R, Ishii M, Sugimura T, et al. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol, 1998, 31: 1074- 1080.
